ArticleBritish journal of cancer2015

MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.

R F H Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.